| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -24,320 | - |
| Stock-based compensation expense | 882 | - |
| Depreciation and amortization | 16 | - |
| Non-cash lease expense | 199 | - |
| Loss on disposal of property and equipment | 0 | - |
| Change in fair value of warrant liability | -517 | - |
| Prepaid expenses and other current assets | -1,606 | - |
| Other assets | 0 | - |
| Accounts payable | 91 | - |
| Accrued expenses and other current liabilities | -4,310 | - |
| Deferred revenue | 0 | - |
| Other liabilities | -518 | - |
| Net cash used in operating activities | -26,871 | - |
| Proceeds from exercise of common stock options | 0 | - |
| Proceeds from issuance of common stock related to employee stock purchase plan | 3 | - |
| Repayment of term loan | 1,216 | - |
| Tax withholding payments on restricted stock units | 0 | - |
| Net cash used in financing activities | -1,213 | - |
| Restricted cash | - | 35 |
| Net decrease in cash, cash equivalents, and restricted cash | -28,084 | - |
| Cash and cash equivalents, at carrying value, ending balance | - | 16,387 |
| Cash and cash equivalents at beginning of period | 38,788 | - |
| Cash and cash equivalents at end of period | 10,704 | 16,422 |
SPRUCE BIOSCIENCES, INC. (SPRB)
SPRUCE BIOSCIENCES, INC. (SPRB)